OSAIC HOLDINGS, INC. - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 1 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$69,000
-46.5%
28,076
-11.3%
0.00%
Q2 2021$129,000
+18.3%
31,635
+31.2%
0.00%
Q1 2021$109,000
+179.5%
24,120
+210.4%
0.00%
Q4 2020$39,000
+77.3%
7,770
+106.1%
0.00%
Q3 2020$22,000
+144.4%
3,770
+5.6%
0.00%
Q2 2020$9,0003,5700.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 3,000,641$29,496,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,308,666$22,694,0000.92%
ArrowMark Colorado Holdings LLC 1,656,422$16,283,0000.16%
IHT Wealth Management, LLC 57,028$561,0000.08%
MOORE CAPITAL MANAGEMENT, LP 50,000$492,0000.02%
Engineers Gate Manager LP 20,264$199,0000.01%
FEDERATED HERMES, INC. 300,000$2,949,0000.01%
FMR LLC 4,048,102$39,793,0000.01%
Invesco Ltd. 1,000,000$9,830,0000.00%
MetLife Investment Management, LLC 14,041$138,0230.00%
View complete list of XERIS PHARMACEUTICALS INC shareholders